Mounjaro (Tirzepatide) 12.5 mg / 0.5 mL Injection

Acquire authentic, brand-name Mounjaro manufactured by Eli Lilly, featuring the highly requested 12.5 mg titration strength as shown in image_2.png. Tirzepatide is a dual GIP and GLP-1 receptor agonist, clinically designed to regulate blood sugar levels and significantly suppress appetite by delaying gastric emptying.

This specific high-dose tier is ideal for individuals continuing their maintenance cycle or stepping up from the 10 mg dosage under their personal research or wellness protocols.

Key Specifications & Box Contents

• Active Ingredient: Tirzepatide (12.5 mg per 0.5 mL dose)

• Packaging: 3 individual boxes available (as pictured in image_2.png), each containing 4 prefilled, single-use automatic injection pens.

• Administration: Once-weekly subcutaneous injection (thigh, abdomen, or upper arm).

• Device Features: Hidden needle design with an automatic lock mechanism for safe and seamless self-administration.

Storage & Handling Information

To maintain maximum peptide stability and efficacy, please ensure adherence to cold-chain guidelines immediately upon arrival:

• Store continuously in a refrigerator between 2°C to 8°C (36°F to 46°F).

• Do not freeze. If a pen becomes frozen, discard it immediately.

• If necessary, an individual pen can be kept at room temperature up to 30°C (86°F) for up to 21 days, away from direct heat and light.